ZIC2 and liver cancer: In particular, the present study revealed that ZIC2 gene expression was positively correlated with immune infiltrating cells in patients with liver cancer, and suggests that ZIC2 can be used as a prognostic biomarker to evaluate low prognosis and high immune infiltration of liver cancer.